menu
    • menu

    Company profile for Muscular Dystrophy Association

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At MDA, we take a big-picture perspective across the full spectrum of neuromuscular diseases to uncover breakthroughs that accelerate treatments and cures. The power in our research approach is that we can often apply learnings from one disease to achieve progress in others to bring urgently needed answers to our families.MDA is the largest source of funding for neuromuscular disease research outside the federal government and...
    At MDA, we take a big-picture perspective across the full spectrum of neuromuscular diseases to uncover breakthroughs that accelerate treatments and cures. The power in our research approach is that we can often apply learnings from one disease to achieve progress in others to bring urgently needed answers to our families.MDA is the largest source of funding for neuromuscular disease research outside the federal government and has committed more than $1 billion in funding since its inception.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Muscular Dystrophy AssociationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    161 N. Clark, Suite 3550 Chicago, Illinois 60601
    Telephone
    Telephone
    800-572-1717
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mda.org/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scholar Rock Presents Phase 3 SAPPHIRE Data at 2025 Conference
    Scholar Rock Presents Phase 3 SAPPHIRE Data at 2025 Conference

    16 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250316203995/en/Scholar-Rock-Presents-New-Phase-3-SAPPHIRE-Data-at-the-2025-Muscular-Dystrophy-Association-Clinical-Scientific-Conference

    BUSINESSWIRE
    16 Mar 2025
    Share Share
    Precision Bio To Present At MDA Clinical & Scientific Conference
    Precision Bio To Present At MDA Clinical & Scientific Conference

    24 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250224445387/en

    BUSINESSWIRE
    24 Feb 2025
    Share Share
    MDA And Forge Biologics Partner On AAV Development
    MDA And Forge Biologics Partner On AAV Development

    09 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240909207887/en

    BUSINESSWIRE
    09 Sep 2024
    Share Share
    Fulcrum Therapeutics Announces Results from ReDUX4 Trial with Losmapimod
    Fulcrum Therapeutics Announces Results from ReDUX4 Trial with Losmapimod

    24 Jun 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/06/24/2252428/0/en/Fulcrum-Therapeutics-Announces-Results-from-ReDUX4-Trial-with-Losmapimod-in-Facioscapulohumeral-Muscular-Dystrophy-FSHD-Demonstrating-Slowed-Disease-Progression-and-Improved-Functi.html

    GLOBENEWSWIRE
    24 Jun 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search